Latest news
AI Model Predicts Late Distant Recurrence Risk in HR-Positive Breast Cancer - Targeted OncologyTargeted Oncology · Sun, 09 Aug 2026 15:05:39 GMTLessons Learned From the OncoPRO Initiative - Targeted OncologyTargeted Oncology · Sun, 09 Aug 2026 00:06:44 GMTCan We Make Stage IV Lung Cancer Curable? New Research Offers Hope - Targeted OncologyTargeted Oncology · Sat, 08 Aug 2026 19:37:56 GMTInetetamab-Pyrotinib Regimen Shows High pCR in HER2-Positive Breast Cancer - Targeted OncologyTargeted Oncology · Sat, 08 Aug 2026 15:11:40 GMTDr Patt Reflects on the Evolution of ePRO Monitoring - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 22:11:35 GMTePRO Monitoring: Earlier Intervention, Fewer Hospitalizations - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 22:00:00 GMTBI-1808 Receives FDA Fast Track Designation in Ovarian Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 20:14:04 GMTLow Physician Density, High Social Vulnerability Predict AlloHCT Gaps Across the US - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 20:07:05 GMT